Related Experiment Video
Updated: Jan 15, 2026

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery
Published on: August 9, 2024
Predictive Value of Combined CRP and INR for Intracranial Hypertension in Cerebral Venous Thrombosis
Jiahui Yan1, Manli Lu1, Zhichao Huang1
1Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Insights
Cerebral venous thrombosis (CVT) patients with high C-reactive protein (CRP) or low international normalized ratio (INR) face increased intracranial hypertension (IH) risk. Combining CRP and INR offers a noninvasive method for assessing IH in CVT.
Area of Science:
- Neurology
- Vascular Medicine
- Biomarker Research
Background:
- Intracranial hypertension (IH) is a significant indicator of severity in cerebral venous thrombosis (CVT).
- Current gold standard for measuring intracranial pressure (ICP) involves invasive lumbar puncture.
- There is a need for noninvasive methods to assess IH in CVT patients for early risk stratification.
Purpose of the Study:
- To develop a noninvasive predictive model for IH in CVT patients.
- To integrate clinical features and biomarkers for improved IH risk assessment.
- To facilitate early risk stratification and management of CVT patients.
Main Methods:
- Consecutive enrollment of CVT patients from January 2011 to June 2024.
- Classification of patients into CVT-IH and CVT+IH groups based on ICP levels.
- Logistic regression analysis using C-reactive protein (CRP) and international normalized ratio (INR) levels, categorized by ROC curves, to determine IH risk.
Main Results:
- 157 patients were included; 61 presented with IH.
- Elevated CRP (>5.5 g/L) or low INR (<0.99) significantly correlated with higher IH incidence.
- A combination of high CRP and low INR increased IH risk by 9.778 times; adding CRP and INR improved IH prediction accuracy in CVT patients.
Conclusions:
- The combined use of CRP and INR effectively predicts IH occurrence in CVT patients.
- This biomarker combination offers a potential noninvasive approach for assessing ICP in CVT.
- Early identification of IH risk in CVT patients can be enhanced through this noninvasive model.
Background:
Intracranial hypertension (IH) is a frequently observed clinical manifestation of cerebral venous thrombosis (CVT), which reflects the severity of the disease. The gold standard of intracranial pressure (ICP) is through invasive lumbar puncture.
Objectives:
We aimed to develop a noninvasive model combining biomarkers and clinical features to predict IH in CVT patients, facilitating early risk stratification.
Methods:
The patients with CVT were consecutively enrolled in the Second Affiliated Hospital of Soochow University and the First Affiliated Hospital of Soochow University between January 2011 and June 2024, which were divided into two groups: CVT-IH group and CVT + IH group based on ICP levels. Additionally, participants were further categorized into four groups according to the cut-off of C-reactive protein (CRP) and international normalized ratio (INR) by the receiver operating characteristic (ROC) curves. Logistic regression models were employed to calculate odds ratios (ORs) and 95% confidence intervals (CIs) of IH across the four subgroups.
Results:
157 individuals were finally included, 61 of whom had IH. Participants with CRP > 5.5 g/L or INR < 0.99 were more likely to experience IH. Those with high CRP and low INR conferred 9.778 times higher risk of IH compared with that of those with low CRP and high INR. Simultaneously adding CRP and INR to the basic model with established risk factors significantly improved risk discrimination and reclassification for IH of CVT patients.
Conclusions:
Combination of CRP and INR better predicted the occurrence of IH for CVT patients, which might provide a noninvasive way of assessing ICP of CVT patients.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

